[Characteristics of intraintestinal absorption of therapeutic solution of gelvisol in normal blood circulation, blood loss and trauma].
D000328:Adult; D000818:Animals; D001775:Blood Circulation; D004285:Dogs; D004338:Drug Combinations; D005971:Glutamates; D006470:Hemorrhage / Q000378:metabolism* / Q000628:therapy; D006601:Hexoses; D006620:Hip Fractures / Q000601:surgery; D006801:Humans; D007408:Intestinal Absorption; D007421:Intestine, Small / Q000378:metabolism*; D008875:Middle Aged; D010952:Plasma Substitutes / Q000378:metabolism* / Q000627:therapeutic use; D011182:Postoperative Care; D051381:Rats; D012996:Solutions
D004338:Drug Combinations; D005971:Glutamates; D006601:Hexoses; D010952:Plasma Substitutes; D012996:Solutions; C016470:ascorbic acid, B2, B6, bendazol, caffeine, citric acid, distilled H2O, ethanol, gelatin, glutamic acid, KCl, MgCl2, NaCl, sorbitol, sucrose, vitamins B1 drug combination
Osobennosti intraintestinal'nogo vsasyvaniia lechebnogo rastvora gel'visola pri normal'nom krovoobrashchenii, krovopotere i travme.